342 related articles for article (PubMed ID: 19577338)
1. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
[TBL] [Abstract][Full Text] [Related]
2. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
4. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease.
Aziz A; Aziz S; Li DS; Murphy L; Leone N; Kennedy M; Dhillon S; Van Thiel DH
J Viral Hepat; 2006 Apr; 13(4):217-21. PubMed ID: 16611186
[TBL] [Abstract][Full Text] [Related]
7. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease.
Keeffe EB; Iwarson S; McMahon BJ; Lindsay KL; Koff RS; Manns M; Baumgarten R; Wiese M; Fourneau M; Safary A; Clemens R; Krause DS
Hepatology; 1998 Mar; 27(3):881-6. PubMed ID: 9500723
[TBL] [Abstract][Full Text] [Related]
9. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
Rosa MN; Hessel G; Alves De Tommaso AM
Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
[TBL] [Abstract][Full Text] [Related]
10. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
Lau DT; Hewlett AT
Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients.
Arguedas MR; Johnson A; Eloubeidi MA; Fallon MB
Hepatology; 2001 Jul; 34(1):28-31. PubMed ID: 11431730
[TBL] [Abstract][Full Text] [Related]
13. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students.
Jabłkowski M; Kuydowicz J; Strzelczyk J; Białkowska J
Med Sci Monit; 2002 Nov; 8(11):CR762-6. PubMed ID: 12444381
[TBL] [Abstract][Full Text] [Related]
15. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
Shapiro AJ; Esther CR; Leigh MW; Dellon EP
Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
[TBL] [Abstract][Full Text] [Related]
16. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease.
Arslan M; Wiesner RH; Sievers C; Egan K; Zein NN
Liver Transpl; 2001 Apr; 7(4):314-20. PubMed ID: 11303291
[TBL] [Abstract][Full Text] [Related]
17. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?
Hernandez B; Hasson NK; Cheung R
Am J Gastroenterol; 2009 Aug; 104(8):1961-7. PubMed ID: 19491840
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a combined vaccine against hepatitis A and B in patients with autoimmune hepatitis.
Beran J; Dedek P; Stepánová V; Spliio M; Pozler O
Cent Eur J Public Health; 2005 Mar; 13(1):20-3. PubMed ID: 15859175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]